These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31380591)

  • 1. Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels.
    Xie Y; Yi W; Zhang L; Lu Y; Hao HX; Gao YJ; Ran CP; Lu HH; Chen QQ; Shen G; Wu SL; Chang M; Ping-Hu L; Liu RY; Sun L; Wan G; Li MH
    J Viral Hepat; 2019 Jul; 26 Suppl 1():42-49. PubMed ID: 31380591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
    Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
    Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for significant histological changes in both HBeAg positive and negative treatment-naive chronic hepatitis B with persistently normal alanine aminotransferase level.
    Xu C; Zhao Y; Chen H; Ren W; Yang X; Zheng W; Yin Q; Pan H
    BMC Infect Dis; 2024 Oct; 24(1):1120. PubMed ID: 39379873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core antigen expression is associated with hepatic necroinflammation in e antigen-negative chronic hepatitis B patients with low DNA loads.
    Huang YH; Hung HH; Chan CC; Lai CR; Chu CJ; Huo TI; Lee PC; Su CW; Lan KH; Huang HC; Lee IC; Lin HC; Lee SD
    Clin Vaccine Immunol; 2010 Jun; 17(6):1048-53. PubMed ID: 20427626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-invasive model for predicting liver fibrosis in HBeAg-positive patients with normal or slightly elevated alanine aminotransferase.
    Li L; Ye Y; Ran Y; Liu S; Tang Q; Liu Y; Liao X; Zhang J; Xiao G; Lu J; Zhang G; He Q; Hu S
    Medicine (Baltimore); 2021 Apr; 100(17):e25581. PubMed ID: 33907107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B.
    Wu R; Zhang Y; Xiang Y; Tang Y; Cui F; Cao J; Zhou L; You Y; Duan L
    J Transl Med; 2018 Apr; 16(1):83. PubMed ID: 29615081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase.
    Zhou J; Song L; Zhao H; Yan L; Ma A; Xie S; Zhang X; Zhang D; Xie Q; Zhang G; Shang J; Cheng J; Zhao W; Zou Z; Zhang M; Xia N; Wang G
    Sci Rep; 2017 Jun; 7(1):2747. PubMed ID: 28584279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spleen thickness can predict significant liver pathology in patients with chronic hepatitis B with persistently normal alanine aminotransferase or minimally raised alanine aminotransferase: a retrospective study.
    Zhang J; Du X; Zhou Z; Lv F; Yu Y
    J Int Med Res; 2019 Jan; 47(1):122-132. PubMed ID: 30213226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume.
    Ke WM; Xie SB; Li XJ; Zhang SQ; Lai J; Ye YN; Gao ZL; Chen PJ
    J Viral Hepat; 2011 Sep; 18(9):637-45. PubMed ID: 21794025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    Papatheodoridis GV; Manesis EK; Manolakopoulos S; Elefsiniotis IS; Goulis J; Giannousis J; Bilalis A; Kafiri G; Tzourmakliotis D; Archimandritis AJ
    Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of serum HBsAg levels, HBsAg/HBV DNA ratio, and association with liver inflammation activity in HBeAg-positive chronic hepatitis B].
    Li G; Wang J; Bao Y; Zheng L; Ge K; Zhou X; Chen G
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):40-5. PubMed ID: 25751385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of liver histological changes and a sustained virological response to peginterferon among chronic hepatitis B e antigen-positive patients with normal or minimally elevated alanine aminotransferase levels.
    Chen J; Xu CR; Xi M; Hu WW; Tang ZH; Zang GQ
    J Viral Hepat; 2017 Jul; 24(7):573-579. PubMed ID: 28107601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal.
    Gao S; Fan YC; Zhao J; Sun FK; Han J; Zhao ZH; Wang K
    Liver Int; 2014 Aug; 34(7):e229-37. PubMed ID: 24112455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China.
    Xing YF; Zhou DQ; He JS; Wei CS; Zhong WC; Han ZY; Peng DT; Shao MM; Sham TT; Mok DK; Chan CO; Tong GD
    PLoS One; 2018; 13(9):e0203220. PubMed ID: 30180183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of anti-HBc and liver inflammation in HBeAg-negative chronic hepatitis B virus-infected patients with normal ALT and detectable HBV DNA.
    Yao K; Wang J; Wang L; Xia J; Yan X; Wu W; Liu J; Wang L; Yin S; Tong X; Ding W; Huang R; Wu C
    J Med Virol; 2022 Feb; 94(2):659-666. PubMed ID: 34499353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.
    Feld JJ; Ayers M; El-Ashry D; Mazzulli T; Tellier R; Heathcote EJ
    Hepatology; 2007 Oct; 46(4):1057-70. PubMed ID: 17654702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.
    Diktas H; Karacaer Z; Özturk II; Cicek H
    Postgrad Med J; 2016 Dec; 92(1094):693-696. PubMed ID: 27170311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B.
    Duan M; Chi X; Xiao H; Liu X; Zhuang H
    Hepatol Int; 2021 Apr; 15(2):318-327. PubMed ID: 33638049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase.
    Gao Y; Wang M; Liu X
    Microbiol Spectr; 2024 Apr; 12(4):e0394123. PubMed ID: 38426768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.
    Shao J; Wei L; Wang H; Sun Y; Zhang LF; Li J; Dong JQ
    World J Gastroenterol; 2007 Apr; 13(14):2104-7. PubMed ID: 17465456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.